You are here: Home > Clients and Projects > Client Projects
 
 

_______________
Agracetus, Inc. / Auragen, Inc. (Middleton, WI)

 

  • Sterile process development for Phase 1 Clinical DNA Product including:
    • System validation of a rigid wall isolator
    • Sterile transfer system
    • Autoclave
    • VHP®1000
  • Environmental monitoring
    • Isolator
    • Laminar flow hoods
    • Manufacturing area
  • Revalidation performed after equipment modification
  • Participation in SOP development and reviews

 
back
 

_______________
Allergan, Inc. (Waco, TX)

 

  • Facility design, review and optimization
    • HVAC air exchanges
    •  Temperature control
  • Validation protocol development and execution
    • Flexible wall sterility test isolator system
    • VHP1000
  • Hydrogen peroxide gas D-value determination of test carriers
 
back
 

_______________
AstraZeneca, Inc. (Westborough, MA)

 

  • Facility design, review and optimization
  • Sterilant generator manifold
  • Validation protocol development and execution
    • Rigid wall sterility test isolator system
    • Autoclave-interface
    • VHP1000
  • Hydrogen peroxide gas D-value determination of test carriers
  • SOP Generation
 
back
 

_______________
Aventis Pasteur (Toronto, Ontario)

 

  • VHP1000 cycle optimization
  • Successful revalidation in an existing sterility test lab
  • VHP1000 PQ
  • Equivalency protocol development and execution
    • Relocated sterility test lab
 
back
 

_______________
Aventis Pasteur Clinical Manufacturing Area (Swiftwater, PA)

 

  • Factory Acceptance Testing (FAT) protocol development
    • Clinical filing facility isolators
  • IQ/OQ/PQ protocol development
  • Execution
    • VHP1000
    • Clinical filling facility isolators
  • Hydrogen peroxide gas D-value determination of test carriers
  • Environmental qualification and monitoring plan development
  • Media fill / sterile challenge protocol development
  • Execution support
 
back
 

_______________
Aventis Pasteur Production Facility (Swiftwater, PA)

 

  • VHP1000 cycle development
  • PQ protocol development and execution
    • Isolated high speed filling line
  • UV D-value determination of test carriers
  • UV pass-through chamber cycle development
  • Validation execution
  • Media fill / sterile challenge assistance
  • Drafted Regulatory Licensing documents (ELA submission)
  • Annual System revalidation testing
 
back
 

_______________
B Braun Medical (Irvine, CA)

 

  • Design consultation (sterilant port locations, control issues)
    • Rigid wall isolator
  • Validation planning
    • Sterile liquid process
    • Powder filling process
  • VHP1000 cycle development
    • First and second filling lines
  • Isolator validation assistance
    • First and second filling lines
 
back
 

_______________
Battelle Memorial Institute (Columbus, OH)

 

  • VMP development
  • Hydrogen peroxide gas D-value determination of test carriers
  • IQ/OQ and PQ protocol development and execution
    • VHP1000
    • Flexible wall sterility testing isolators
 
back
 

_______________
Baxter Healthcare Corp. (Boulder, CO)

 

  • IQ/OQ, cycle development, and PQ protocol development
    • VHPM1000
    • Clinical filling isolator
  • Execution
    • Clinical filling isolator
  • IQ/OQ and PQ protocol development and execution
    • VHP1000
    • Sterility testing isolator
  • Hydrogen peroxide gas D-value determination of test carriers
 
back
 

_______________
Baxter Healthcare Corp. (Round Lake, IL, and Lessines, Belgium)

 

  • VHP1000 manifold design
    • Sterile liquid processing isolator
  • System specification and design review
    • Rigid wall sterility test isolator
 
back
 

_______________
Biopure, Inc. (Cambridge, MA)

 

  • System specification and design review
    • Rigid wall sterility test isolator system
  • Hydrogen peroxide gas D-value determination of test carriers
  • IQ/OQ and PQ protocol development and execution
    • VHP1000
    • Sterility testing isolators
  • Design review
    • Hydrogen peroxide liquid
    • Hydrogen peroxide spray/fog
    • Hydrogen peroxide gas
    • Steam sterilization processes
    • Form-Fill-Seal machine used for IV solution filling
 
back
 

_______________
BioReliance Corporation (Rockville, MD)

 

  • Facility review, design consultation, and process development
    • Sterile batch injectable clinical filling line application inside a rigid wall isolator system  using hydrogen peroxide gas decontamination 
  • Cycle development testing
    • VHP1000
  • IQ/OQ/PQ protocol development and execution for multiple rigid wall isolator systems
    • Filling
    • Autoclave interface
    • Transfer
    • Two VHP1000s
 
back
 

_______________
DuPont-Merck Pharmaceutical (Wilmington, DE)

 

  • Set-up and system optimization
    • Flexible wall sterility test isolator
  • VHP1000 training
  • Validation training
 
back
 

_______________
GlaxoSmithKline (Research Triangle Park, NC)

 

  • Facility design review and optimization
    • HVAC air exchanges
    • Exhaust systems
  • Validation protocol reviews and execution assistance
    • Flexible wall sterility test isolators with autoclave interface system

 

            
 ""
      

 
back
 

_______________
Haines, Lundberg & Waehler (New York, NY)

 

  • Hydrogen peroxide gas manifold system design review
    • BSL3 animal room decontamination
    • (US government facility project)
 
back
 

_______________
la Calhene, Inc. (Rush City, MN)

 

  • Hydrogen peroxide residue testing
    • Potential rigid wall isolator materials
 
back
 

_______________
Laboratoires Merck, Sharpe & Dohme - Chibret (MSD Clermont-Ferrand, France)

 

  • Design consultation and process development
    • Sterile batch ophthalmic filling line application inside a rigid wall isolator system  using hydrogen peroxide gas decontamination
  • Factory Acceptance Testing (FAT) cycle development testing
    • VHP1001 filling line isolators located in France and Italy
  • IQ/OQ and PQ protocol development
    • Three (3) rigid wall isolators
    • One (1) soft wall isolator
    • Three (3) VHP1001s
  • Execution
    • Three (3) rigid wall isolators
    • One (1) soft wall isolator
    • Three (3) VHP1001s
  • Hydrogen peroxide gas D-value determination of test carriers
  • Successful revalidation
    • Decontamination cycle
 
back
 

_______________
Laboratoires Merck, Sharpe & Dohme - Chibret (MSD Clermont-Ferrand, France)

 

  • Hydrogen peroxide gas D-value determination of test carriers
  • IQ/OQ, PQ, and VHP1001 equivalency protocol development for second identical ophthalmic filling line inside an isolator system
  • Execution
    • Second identical ophthalmic filling line inside an isolator system
 
back
 

_______________
Laboratoires Merck, Sharpe & Dohme - Chibret (MSD Clermont-Ferrand, France)

 

  • Design consultation and process development
    • Sterile batch injectable filling line application inside a rigid wall isolator system using hydrogen peroxide gas decontamination
  • VHP1001 cycle development testing in conjunction with isolator vendor
  • IQ/OQ and PQ protocol development
    • Multiple rigid wall isolator systems
    • Flexible wall isolators
  • Execution
    • Multiple rigid wall isolator systems
    • Flexible wall isolators
  • Equivalency studies for Multiple VHP1001s using NIR sensor technology
 
back
 

_______________
Lancaster Labs (Lancaster, PA)

 

  • Facility design review and optimization
    • HVAC air exchanges
    • Temperature control
  • Validation protocol development and execution
    • Flexible wall sterility test isolator system
  • Successful revalidation of decontamination cycles
    • Second VHP1000
  • Equivalency testing
    • Second VHP1000
  • Sterility test isolator suite
    • New laboratory design review
    • Exhaust system design/qualification
    • Post-relocation equivalency revalidation studies
  • Hydrogen peroxide gas D-value determination of test carriers
  • IQ/OQ and PQ protocol development and execution
    • Double-door autoclave and adjoining interface isolator
 
back
 

_______________
Merck & Co., Inc. (Elkton, VA)

 

 

  • Design consultation and process development
    • Sterile bulk powder filling application in rigid wall isolators using hydrogen peroxide decontamination, including sterilant manifold systems in production areas
  • Sterilizable transfer system development assistance
    • Bulk powder transport and delivery in disposable bags
  • IQ/OQ and Factory Acceptance Testing (FAT) cycle development
    • VHP1000
  • Hydrogen peroxide gas D-value determination of test carriers
  • PQ protocol development for execution
    • 5 isolators
    • 5 VHP1000s
    • Successful equivalency studies on the multiple generator system
 
back
 

_______________
Merck & Co., Inc. (West Point, PA)

 

  • Barrier technology prototype research, development, and feasibility testing
  • Peroxide Plus (steam/Hydrogen Peroxide) sterilization methods development and testing
  • Factory Acceptance Testing (FAT), protocol development and execution
    • High speed barrier filling system
    • Depyrogenation tunnel
    • SIP
    • Related systems
  • IQ/OQ protocol development and execution
    • High speed barrier filling system
    • Depyrogenation tunnel
    • CIP/SIP
    • Related systems
 
back
 

_______________
Merck & Co., Inc. (West Point, PA: BTMC- Biotechnology Manufacturing)

 

  • Leak remediation
    • Prototype seed lab isolator system
  • IQ/OQ and PQ protocol development for VHP1000
  • Execution
    • Multiple isolator system
 
back
 

_______________
Monsanto (Augusta, GA)

 

  • Facility design review and optimization
    • HVAC air exchanges
    • Temperature control
  • Factory Acceptance Testing (FAT) studies at isolator vendor
  • Hydrogen peroxide gas D-value determination of test carriers
  • Validation protocol development and execution
    • Rigid wall filling line and sterility test isolator systems using multiple VHP1000s and VHPM1000s
 
back
 

_______________
Novex Pharma, Inc. (Richmond Hill, Ontario)

 

  • Hydrogen peroxide gas manifold system development
    • Production ophthalmic barrier filling system
  • Hydrogen peroxide gas manifold system
    • Clinical injectable barrier filling system
  • Protocol development and execution
    • VHP1000
  • Cycle development
    • Three (3) rigid wall isolators comprising the injectable barrier filling system with oven and  autoclave interface
  • Hydrogen peroxide gas D-value determination of test carriers
  • Design review, protocol development, and execution of hydrogen peroxide gas cycle development studies
    • High speed injectalbe filling line interface to 2 VHP1000s in parallel
 
back
 

_______________
Pharmacia (Kalamazoo, MI)

 

  • Hydrogen peroxide gas process development, validation strategy consultation, and cycle development or high speed barrier filling system
 
back
 

_______________
PSGA / Johnson & Johnson (Buenos Aires, Argentina)

 

  • Facility design review and optimization
  • Validation protocol development and execution
    • Rigid wall sterility isolator system
    • Two VHP1001s
  • Hydrogen peroxide gas D-value determination of test carriers
  • SOP Generation
 
back
 

_______________
Rhône-Poulenc Rorer Central Research (Collegeville, PA)

 

  • Facility design review and optimization
    •  HVAC
    • Outside exhaust system
  • Isolator design optimization to permit VHP1000 decontamination
    • Fan istallation
    • Eradication of leaks
    • Materials optimization
  • Validation protocol development and execution
    • Rigid wall sterility test isolator system with autoclave interface
 
back
 

_______________
Robert Bosch GmbH (Crailsheim, Germany)

 

  • Design consultation and process development (sterilization specifications)
    • Sterile filling application involving isolation and hydrogen peroxide gas decontaminatio""
  • Factory Acceptance Testing (FAT) protocol development
 
back
 

_______________
Wyeth Laboratories (Marietta, PA)

 

  • Facility design review and optimization
    • HVAC air exchanges
    • Temperature control
  • Validation protocol development and execution
    • Flexible wall sterility test isolator system
    • VHP1000
 
back
 

_______________
Wyeth Laboratories (West Chester, PA)

 

  • Process development, feasibility testing, and validation
    • Surface sterilization of an antibiotic centrifuge/dryer system using hydrogen peroxide gas
  • IQ/OQ and PQ protocol development and execution
    • Two (2) VHP1000 generators in tandem including manifold piping design and testing
 
back
 

_______________
Wyeth Lederle Vaccines & Pediatrics (Sanford, NC)

 

  • IQ/OQ and PQ protocol and cycle development assistance
    •  Flexible wall sterility test isolators
    • VHP1000
 
back
 
 
 
 

____________________
 

Two locations to better serve clients worldwide.
 

USA Europe
150 Iowa Lane
Cary, NC  27511-4496
(919) 469-8876
(919) 469-4665 Fax
2 Avenue de Vignate
38610 Gieres, France
+33 4 76 63 48 74
+33 4 76 63 48 75 Fax

©2009 Advanced Barrier Concepts, Inc. All rights reserved.
Site Maintained By:
Bayfront Web Design